Solitary colorectal liver metastasis: resection determines outcome.

PubWeight™: 2.06‹?› | Rank: Top 2%

🔗 View Article (PMID 16702517)

Published in Arch Surg on May 01, 2006

Authors

Thomas A Aloia1, Jean-Nicolas Vauthey, Evelyne M Loyer, Dario Ribero, Timothy M Pawlik, Steven H Wei, Steven A Curley, Daria Zorzi, Eddie K Abdalla

Author Affiliations

1: Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77230-1402, USA.

Articles citing this

Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol (2009) 2.17

The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist (2012) 1.76

Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol (2012) 1.69

Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection. Int J Radiat Oncol Biol Phys (2015) 1.52

Complications of intraoperative radiofrequency ablation of liver metastases. HPB (Oxford) (2010) 1.48

Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. World J Gastroenterol (2011) 1.20

Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery (2011) 1.17

Role of surgery in colorectal cancer liver metastases. World J Gastroenterol (2014) 1.13

Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. Radiology (2009) 1.08

Actual role of radiofrequency ablation of liver metastases. Eur Radiol (2007) 1.07

Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc (2011) 1.04

New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res (2007) 1.03

Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol (2011) 1.02

Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings. HPB (Oxford) (2007) 0.98

Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol (2014) 0.97

Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol (2014) 0.97

Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression. Ann Surg Oncol (2011) 0.96

Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver (2012) 0.93

Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford) (2011) 0.93

Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg (2007) 0.91

Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol (2014) 0.88

A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment. BMC Cancer (2010) 0.87

Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging (2011) 0.86

Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (Oxford) (2007) 0.86

Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases. HPB Surg (2010) 0.85

Recurrence after microwave ablation of liver malignancies: a single institution experience. HPB (Oxford) (2012) 0.85

Hypofractionated radiotherapy with tomotherapy for patients with hepatic oligometastases: retrospective analysis of two institutions. Clin Exp Metastasis (2013) 0.83

Current perioperative outcomes for patients with disseminated cancer. J Surg Res (2015) 0.83

Optimal timing of systemic therapy in resectable colorectal liver metastases. Am Surg (2013) 0.83

Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases. World J Surg (2009) 0.82

Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer. World J Gastroenterol (2014) 0.82

Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases. World J Surg Oncol (2009) 0.81

Short- and long-term results of extended left hepatectomy for colorectal metastases. HPB (Oxford) (2011) 0.81

Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions. J Radiat Res (2016) 0.81

Evolving ablative therapies for hepatic malignancy. Biomed Res Int (2014) 0.80

Selection criteria for combined resection of synchronous colorectal cancer hepatic metastases: a cautionary note. Int J Colorectal Dis (2014) 0.80

Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery. J Gastrointest Surg (2015) 0.80

Which parameters are needed for targeting a multitined radiofrequency device--an approach to a simple algorithm. Langenbecks Arch Surg (2008) 0.79

Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors. HPB (Oxford) (2015) 0.79

MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions. Eur Radiol (2012) 0.79

Current strategies in interventional oncology of colorectal liver metastases. Br J Radiol (2016) 0.79

Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases. J Am Coll Surg (2016) 0.78

Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors. Cardiovasc Intervent Radiol (2015) 0.78

Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases. J Gastrointest Oncol (2014) 0.78

Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model. PLoS One (2015) 0.77

Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg (2011) 0.77

Accomplishments in 2007 in the management of curable metastatic colorectal cancer. Gastrointest Cancer Res (2008) 0.77

The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer. Medicine (Baltimore) (2016) 0.77

Managing potentially resectable metastatic colon cancer. Gastrointest Cancer Res (2008) 0.76

Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models. PLoS One (2016) 0.76

Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases: an analysis of 395 patients. World J Surg (2013) 0.76

Surgery for oligometastasis of pancreatic cancer. Chin J Cancer Res (2015) 0.76

The case for neo-adjuvant chemotherapy. For. Ann R Coll Surg Engl (2008) 0.75

Stereotactic ablative radiotherapy for oligometastatic disease in liver. Biomed Res Int (2014) 0.75

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. World J Surg Oncol (2016) 0.75

Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report. BMC Cancer (2015) 0.75

Colorectal cancer liver metastasis trends in the kingdom of Saudi Arabia. Saudi J Gastroenterol (2016) 0.75

Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature. BMC Cancer (2014) 0.75

Outcomes of rectal cancer with liver oligometastases. J Gastrointest Oncol (2014) 0.75

Management of oligometastatic rectal cancer: is liver first? J Gastrointest Oncol (2015) 0.75

Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis. Chin Med J (Engl) (2016) 0.75

Radiofrequency ablation or resection for small colorectal liver metastases - a plea for caution. Quant Imaging Med Surg (2013) 0.75

Minimally invasive evaluation and treatment of colorectal liver metastases. Int J Surg Oncol (2011) 0.75

Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical Practice. PLoS One (2016) 0.75

Outcome after hepatic resection of solitary liver metastasis from colorectal cancer in the caudate lobe. World J Surg (2007) 0.75

Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours. J Cancer Res Clin Oncol (2017) 0.75

A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation. Surg Endosc (2016) 0.75

Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases. World J Surg (2014) 0.75

Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer. Visc Med (2017) 0.75

The clinical risk score predicts the effectiveness of adjuvant chemotherapy for colorectal liver metastasis. World J Surg (2015) 0.75

Articles by these authors

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol (2008) 15.05

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol (2009) 5.42

The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33

A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg (2013) 4.95

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86

Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet (2011) 4.38

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol (2008) 4.37

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 4.34

Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg (2007) 4.09

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov (2011) 3.86

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol (2008) 3.51

Simplified staging for hepatocellular carcinoma. J Clin Oncol (2002) 3.48

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 3.45

Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol (2007) 3.45

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg (2008) 3.36

NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol (2009) 3.22

Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16

Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15

Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Hepatology (2014) 2.98

Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.96

Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Natl Acad Sci U S A (2006) 2.91

Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol (2003) 2.85

Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer (2007) 2.83

Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.66

Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg (2004) 2.62

Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg (2002) 2.62

Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg (2007) 2.62

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol (2008) 2.52

Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg (2009) 2.44

Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl (2005) 2.43

Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol (2007) 2.40

Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol (2005) 2.38

Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg (2013) 2.36

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA (2009) 2.35

Preoperative portal vein embolization for extended hepatectomy. Ann Surg (2003) 2.33

Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg (2012) 2.29

High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol (2011) 2.28

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol (2009) 2.27

Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol (2007) 2.26

Intrahepatic cholangiocarcinoma: management options and emerging therapies. J Am Coll Surg (2013) 2.22

Body surface area and body weight predict total liver volume in Western adults. Liver Transpl (2002) 2.21

Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg (2003) 2.20

Modified Makuuchi incision for foregut procedures. Arch Surg (2010) 2.15

Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13

Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev (2009) 2.12

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer (2007) 2.12

Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol (2006) 2.12

Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol (2007) 2.06